|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:SVT
gptkb:drug
|
|
gptkbp:affects
|
gptkb:healthcare_organization
|
|
gptkbp:can_be
|
gptkb:theorem
|
|
gptkbp:can_lead_to
|
stroke
heart failure
|
|
gptkbp:caused_by
|
irregular heartbeat
|
|
gptkbp:focuses_on
|
cardiology research
|
|
gptkbp:has_style
|
gptkb:theorem
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
atrial fibrillation
|
|
gptkbp:inscription
|
underlying heart disease
|
|
gptkbp:is_aimed_at
|
stress
alcohol consumption
caffeine consumption
hyperthyroidism
|
|
gptkbp:is_associated_with
|
hypertension
increased healthcare costs
coronary artery disease
valvular heart disease
|
|
gptkbp:is_influenced_by
|
gptkb:physicist
lifestyle factors
medications
|
|
gptkbp:is_maintained_by
|
gptkb:theorem
|
|
gptkbp:is_monitored_by
|
gptkb:hospital
|
|
gptkbp:is_often_associated_with
|
gptkb:historical_event
anxiety
|
|
gptkbp:is_often_compared_to
|
hospitalized patients
|
|
gptkbp:is_often_depicted_as
|
men
people with diabetes
people with sleep apnea
|
|
gptkbp:is_often_used_in
|
older adults
|
|
gptkbp:is_part_of
|
cardiovascular diseases
|
|
gptkbp:is_recognized_by
|
gptkb:healthcare_organization
gptkb:World_Health_Organization
|
|
gptkbp:is_studied_in
|
clinical trials
|
|
gptkbp:managed_by
|
patient education
lifestyle changes
cardioversion
catheter ablation
|
|
gptkbp:par
|
gptkb:theorem
|
|
gptkbp:recognizes
|
gptkb:Holter_monitor
event monitor
|
|
gptkbp:risk_factor
|
gptkb:psychologist
heart attack
pulmonary embolism
|
|
gptkbp:scientific_classification
|
lone atrial fibrillation
secondary atrial fibrillation
|
|
gptkbp:social_responsibility
|
electrocardiogram (ECG)
|
|
gptkbp:subject
|
public health initiatives
|
|
gptkbp:symptoms
|
fatigue
shortness of breath
palpitations
|
|
gptkbp:treatment
|
anticoagulants
emergency settings
beta-blockers
antiarrhythmic drugs
|